A Phase 2a Study of PRV-6527 (JNJ-40346527) in patients with moderate to severe Crohn's disease

Trial Profile

A Phase 2a Study of PRV-6527 (JNJ-40346527) in patients with moderate to severe Crohn's disease

Planning
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2017

At a glance

  • Drugs PRV-6527 (Primary)
  • Indications Crohn's disease
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 26 Sep 2017 New trial record
    • 21 Sep 2017 According to a Provention Bio media release, the company anticipates initiating enrollment in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top